Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia

NCT01757873 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia

Interventions

DRUG: Z160
DRUG: Placebo

Sponsor

Zalicus